The cell cycle in Alzheimer disease: A unique target for neuropharmacology
- 31 October 2005
- journal article
- review article
- Published by Elsevier BV in Mechanisms of Ageing and Development
- Vol. 126 (10), 1019-1025
- https://doi.org/10.1016/j.mad.2005.03.024
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Mefenamic acid-induced apoptosis in human liver cancer cell-lines through caspase-3 pathwayLife Sciences, 2004
- The current status of Alzheimer?s disease genetics: what do we tell the patients?Pharmacological Research, 2004
- The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s DiseaseNeurosignals, 2002
- Cyclin' toward dementiaJournal of Neuroscience Research, 2000
- Presenilin Overexpression Arrests Cells in the G1 Phase of the Cell Cycle: Arrest Potentiated by the Alzheimer's Disease PS2(N141I. MutantThe American Journal of Pathology, 1999
- Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal DeathPublished by Elsevier BV ,1999
- Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer diseaseMedical Hypotheses, 1999
- Static Cytofluorometry and Fluorescence Morphology of Mitochondria and DNA in Proliferating FibroblastsBiotechnic & Histochemistry, 1996
- Abnormal Alzheimer‐like phosphorylation of tau‐protein by cyclin‐dependent kinases cdk2 and cdk5FEBS Letters, 1993
- Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's diseaseFEBS Letters, 1992